Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 56 entries
Sorted by: Best Match Show Resources per page
[Phonocardiography and differential diagnosis of heart damage in the attack-free course of rheumatism and functional changes in the cardiovascular system in children].

Pediatriia

Liubavin IaG, Kochkin VI.
PMID: 5533284
Pediatriia. 1970 Apr;49(4):44-7.

No abstract available.

Cite
Liubavin IaG, Kochkin VI. Fonokardiografiia v differentsial'noĭ diagnostike porazheniia serdtsa pri bespristupo tekushchem revmatizme i funktsional'nykh izmeniniiakh serdechno-sosudistoĭ sistemy u deteĭ. [Phonocardiography and differential diagnosis of heart damage in the attack-free course of rheumatism and functional changes in the cardiovascular system in children]. Pediatriia. 1970;49(4):44-7
Liubavin, I. a. G., & Kochkin, V. I. (1970). Fonokardiografiia v differentsial'noĭ diagnostike porazheniia serdtsa pri bespristupo tekushchem revmatizme i funktsional'nykh izmeniniiakh serdechno-sosudistoĭ sistemy u deteĭ. [Phonocardiography and differential diagnosis of heart damage in the attack-free course of rheumatism and functional changes in the cardiovascular system in children]. Pediatriia, 49(4), 44-7.
Liubavin, Ia G, and Kochkin, V I. "Fonokardiografiia v differentsial'noĭ diagnostike porazheniia serdtsa pri bespristupo tekushchem revmatizme i funktsional'nykh izmeniniiakh serdechno-sosudistoĭ sistemy u deteĭ." [Phonocardiography and differential diagnosis of heart damage in the attack-free course of rheumatism and functional changes in the cardiovascular system in children]. Pediatriia vol. 49,4 (1970): 44-7.
Liubavin IaG, Kochkin VI. Fonokardiografiia v differentsial'noĭ diagnostike porazheniia serdtsa pri bespristupo tekushchem revmatizme i funktsional'nykh izmeniniiakh serdechno-sosudistoĭ sistemy u deteĭ. [Phonocardiography and differential diagnosis of heart damage in the attack-free course of rheumatism and functional changes in the cardiovascular system in children]. Pediatriia. 1970 Apr;49(4):44-7. Russian. PMID: 5533284.
Copy Download .nbib Format: NLM
Highly efficient optical director reorientation of liquid-crystalline polymer induced by dye additives.

Physical review. E

Budagovsky IA, Ochkin VN, Shvetsov SA, Zolot'ko AS, Bobrovsky AY, Boiko NI, Shibaev VP.
PMID: 28618539
Phys Rev E. 2017 May;95(5):052705. doi: 10.1103/PhysRevE.95.052705. Epub 2017 May 31.

Light-induced director orientation of polymeric liquid-crystalline systems was investigated. The materials under study were composed of a nematic liquid-crystalline polymer (NLCP) and a small amount (0.05-0.5 wt.%) of conformationally active (azobenzene) or stable (anthraquinone) dye impurity. Light action on...

Cite
Budagovsky IA, Ochkin VN, Shvetsov SA, et al. Highly efficient optical director reorientation of liquid-crystalline polymer induced by dye additives. Phys Rev E. 2017;95(5):052705doi: 10.1103/PhysRevE.95.052705.
Budagovsky, I. A., Ochkin, V. N., Shvetsov, S. A., Zolot'ko, A. S., Bobrovsky, A. Y., Boiko, N. I., & Shibaev, V. P. (2017). Highly efficient optical director reorientation of liquid-crystalline polymer induced by dye additives. Physical review. E, 95(5), 052705. https://doi.org/10.1103/PhysRevE.95.052705
Budagovsky, I A, et al. "Highly efficient optical director reorientation of liquid-crystalline polymer induced by dye additives." Physical review. E vol. 95,5 (2017): 052705. doi: https://doi.org/10.1103/PhysRevE.95.052705
Budagovsky IA, Ochkin VN, Shvetsov SA, Zolot'ko AS, Bobrovsky AY, Boiko NI, Shibaev VP. Highly efficient optical director reorientation of liquid-crystalline polymer induced by dye additives. Phys Rev E. 2017 May;95(5):052705. doi: 10.1103/PhysRevE.95.052705. Epub 2017 May 31. PMID: 28618539.
Copy Download .nbib Format: NLM
Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials.

Therapeutic advances in urology

Koshkin VS, Small EJ.
PMID: 30574205
Ther Adv Urol. 2018 Nov 11;10(12):445-454. doi: 10.1177/1756287218811450. eCollection 2018 Dec.

Apalutamide (ARN-509) is a second-generation androgen receptor (AR) antagonist that was developed to inhibit AR-mediated prostate cancer cell proliferation. Following the initial promising clinical efficacy results in phase I and II clinical trials of patients with metastatic castrate-resistant prostate...

Cite
Koshkin VS, Small EJ. Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials. Ther Adv Urol. 2018;10(12):445-454doi: 10.1177/1756287218811450.
Koshkin, V. S., & Small, E. J. (2018). Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials. Therapeutic advances in urology, 10(12), 445-454. https://doi.org/10.1177/1756287218811450
Koshkin, Vadim S, and Small, Eric J. "Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials." Therapeutic advances in urology vol. 10,12 (2018): 445-454. doi: https://doi.org/10.1177/1756287218811450
Koshkin VS, Small EJ. Apalutamide in the treatment of castrate-resistant prostate cancer: evidence from clinical trials. Ther Adv Urol. 2018 Nov 11;10(12):445-454. doi: 10.1177/1756287218811450. eCollection 2018 Dec. PMID: 30574205; PMCID: PMC6295778.
Copy Download .nbib Format: NLM
Binding energies and nonradiative decay rates of Hed micro molecular ions.

Physical review. A, Atomic, molecular, and optical physics

Belyaev VB, Kartavtsev OI, Kochkin VI, Kolganova EA.
PMID: 9912420
Phys Rev A. 1995 Aug;52(2):1765-1768. doi: 10.1103/physreva.52.1765.

No abstract available.

Cite
Belyaev VB, Kartavtsev OI, Kochkin VI, et al. Binding energies and nonradiative decay rates of Hed micro molecular ions. Phys Rev A. 1995;52(2):1765-1768doi: 10.1103/physreva.52.1765.
Belyaev, V. B., Kartavtsev, O. I., Kochkin, V. I., & Kolganova, E. A. (1995). Binding energies and nonradiative decay rates of Hed micro molecular ions. Physical review. A, Atomic, molecular, and optical physics, 52(2), 1765-1768. https://doi.org/10.1103/physreva.52.1765
Belyaev, et al. "Binding energies and nonradiative decay rates of Hed micro molecular ions." Physical review. A, Atomic, molecular, and optical physics vol. 52,2 (1995): 1765-1768. doi: https://doi.org/10.1103/physreva.52.1765
Belyaev VB, Kartavtsev OI, Kochkin VI, Kolganova EA. Binding energies and nonradiative decay rates of Hed micro molecular ions. Phys Rev A. 1995 Aug;52(2):1765-1768. doi: 10.1103/physreva.52.1765. PMID: 9912420.
Copy Download .nbib Format: NLM
CD8.

Cancer immunology research

Kikuchi Y, Tokita S, Hirama T, Kochin V, Nakatsugawa M, Shinkawa T, Hirohashi Y, Tsukahara T, Hata F, Takemasa I, Sato N, Kanaseki T, Torigoe T.
PMID: 34433589
Cancer Immunol Res. 2021 Nov;9(11):1342-1353. doi: 10.1158/2326-6066.CIR-20-0964. Epub 2021 Aug 25.

CD8

Cite
Kikuchi Y, Tokita S, Hirama T, et al. CD8. Cancer Immunol Res. 2021;9(11):1342-1353doi: 10.1158/2326-6066.CIR-20-0964.
Kikuchi, Y., Tokita, S., Hirama, T., Kochin, V., Nakatsugawa, M., Shinkawa, T., Hirohashi, Y., Tsukahara, T., Hata, F., Takemasa, I., Sato, N., Kanaseki, T., & Torigoe, T. (2021). CD8. Cancer immunology research, 9(11), 1342-1353. https://doi.org/10.1158/2326-6066.CIR-20-0964
Kikuchi, Yasuhiro, et al. "CD8." Cancer immunology research vol. 9,11 (2021): 1342-1353. doi: https://doi.org/10.1158/2326-6066.CIR-20-0964
Kikuchi Y, Tokita S, Hirama T, Kochin V, Nakatsugawa M, Shinkawa T, Hirohashi Y, Tsukahara T, Hata F, Takemasa I, Sato N, Kanaseki T, Torigoe T. CD8. Cancer Immunol Res. 2021 Nov;9(11):1342-1353. doi: 10.1158/2326-6066.CIR-20-0964. Epub 2021 Aug 25. PMID: 34433589.
Copy Download .nbib Format: NLM
[No title available]

Journal for immunotherapy of cancer

de Kouchkovsky I, Zhang L, Philip EJ, Wright F, Kim DM, Natesan D, Kwon D, Ho H, Ho S, Chan E, Porten SP, Wong AC, Desai A, Huang FW, Chou J, Oh DY, Pruthi RS, Fong L, Small EJ, Friedlander TW, Koshkin VS.
PMID: 33980590
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002127.

BACKGROUND: Immune checkpoint inhibitors (ICI) can achieve durable responses in a subset of patients with locally advanced or metastatic urothelial carcinoma (aUC). The use of tumor genomic profiling in clinical practice may help suggest biomarkers to identify patients most...

Cite
de Kouchkovsky I, Zhang L, Philip EJ, et al. . J Immunother Cancer. 2021;9(5)doi: 10.1136/jitc-2020-002127.
de Kouchkovsky, I., Zhang, L., Philip, E. J., Wright, F., Kim, D. M., Natesan, D., Kwon, D., Ho, H., Ho, S., Chan, E., Porten, S. P., Wong, A. C., Desai, A., Huang, F. W., Chou, J., Oh, D. Y., Pruthi, R. S., Fong, L., Small, E. J., Friedlander, T. W., & Koshkin, V. S. (2021). . Journal for immunotherapy of cancer, 9(5), . https://doi.org/10.1136/jitc-2020-002127
de Kouchkovsky, Ivan, et al. "." Journal for immunotherapy of cancer vol. 9,5 (2021). doi: https://doi.org/10.1136/jitc-2020-002127
de Kouchkovsky I, Zhang L, Philip EJ, Wright F, Kim DM, Natesan D, Kwon D, Ho H, Ho S, Chan E, Porten SP, Wong AC, Desai A, Huang FW, Chou J, Oh DY, Pruthi RS, Fong L, Small EJ, Friedlander TW, Koshkin VS. . J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002127. PMID: 33980590; PMCID: PMC8118032.
Copy Download .nbib Format: NLM
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.

JAMA oncology

Thompson MA, Henderson JP, Shah PK, Rubinstein SM, Joyner MJ, Choueiri TK, Flora DB, Griffiths EA, Gulati AP, Hwang C, Koshkin VS, Papadopoulos EB, Robilotti EV, Su CT, Wulff-Burchfield EM, Xie Z, Yu PP, Mishra S, Senefeld JW, Shah DP, Warner JL.
PMID: 34137799
JAMA Oncol. 2021 Jun 17; doi: 10.1001/jamaoncol.2021.1799. Epub 2021 Jun 17.

IMPORTANCE: COVID-19 is a life-threatening illness for many patients. Prior studies have established hematologic cancers as a risk factor associated with particularly poor outcomes from COVID-19. To our knowledge, no studies have established a beneficial role for anti-COVID-19 interventions...

Cite
Thompson MA, Henderson JP, Shah PK, et al. Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19. JAMA Oncol. 2021;doi: 10.1001/jamaoncol.2021.1799.
Thompson, M. A., Henderson, J. P., Shah, P. K., Rubinstein, S. M., Joyner, M. J., Choueiri, T. K., Flora, D. B., Griffiths, E. A., Gulati, A. P., Hwang, C., Koshkin, V. S., Papadopoulos, E. B., Robilotti, E. V., Su, C. T., Wulff-Burchfield, E. M., Xie, Z., Yu, P. P., Mishra, S., Senefeld, J. W., Shah, D. P., Warner, J. L. (2021). Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19. JAMA oncology, . https://doi.org/10.1001/jamaoncol.2021.1799
Thompson, Michael A, et al. "Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19." JAMA oncology vol. (2021). doi: https://doi.org/10.1001/jamaoncol.2021.1799
Thompson MA, Henderson JP, Shah PK, Rubinstein SM, Joyner MJ, Choueiri TK, Flora DB, Griffiths EA, Gulati AP, Hwang C, Koshkin VS, Papadopoulos EB, Robilotti EV, Su CT, Wulff-Burchfield EM, Xie Z, Yu PP, Mishra S, Senefeld JW, Shah DP, Warner JL. Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19. JAMA Oncol. 2021 Jun 17; doi: 10.1001/jamaoncol.2021.1799. Epub 2021 Jun 17. PMID: 34137799; PMCID: PMC8377563.
Copy Download .nbib Format: NLM
A terrestrial gamma-ray flash and ionospheric ultraviolet emissions powered by lightning.

Science (New York, N.Y.)

Neubert T, Østgaard N, Reglero V, Chanrion O, Heumesser M, Dimitriadou K, Christiansen F, Budtz-Jørgensen C, Kuvvetli I, Rasmussen IL, Mezentsev A, Marisaldi M, Ullaland K, Genov G, Yang S, Kochkin P, Navarro-Gonzalez J, Connell PH, Eyles CJ.
PMID: 31826957
Science. 2020 Jan 10;367(6474):183-186. doi: 10.1126/science.aax3872. Epub 2019 Dec 11.

Terrestrial gamma-ray flashes (TGFs) are transient gamma-ray emissions from thunderstorms, generated by electrons accelerated to relativistic energies in electric fields. Elves are ultraviolet and optical emissions excited in the lower ionosphere by electromagnetic waves radiated from lightning current pulses....

Cite
Neubert T, Østgaard N, Reglero V, et al. A terrestrial gamma-ray flash and ionospheric ultraviolet emissions powered by lightning. Science. 2019;367(6474):183-186doi: 10.1126/science.aax3872.
Neubert, T., Østgaard, N., Reglero, V., Chanrion, O., Heumesser, M., Dimitriadou, K., Christiansen, F., Budtz-Jørgensen, C., Kuvvetli, I., Rasmussen, I. L., Mezentsev, A., Marisaldi, M., Ullaland, K., Genov, G., Yang, S., Kochkin, P., Navarro-Gonzalez, J., Connell, P. H., & Eyles, C. J. (2020). A terrestrial gamma-ray flash and ionospheric ultraviolet emissions powered by lightning. Science (New York, N.Y.), 367(6474), 183-186. https://doi.org/10.1126/science.aax3872
Neubert, Torsten, et al. "A terrestrial gamma-ray flash and ionospheric ultraviolet emissions powered by lightning." Science (New York, N.Y.) vol. 367,6474 (2020): 183-186. doi: https://doi.org/10.1126/science.aax3872
Neubert T, Østgaard N, Reglero V, Chanrion O, Heumesser M, Dimitriadou K, Christiansen F, Budtz-Jørgensen C, Kuvvetli I, Rasmussen IL, Mezentsev A, Marisaldi M, Ullaland K, Genov G, Yang S, Kochkin P, Navarro-Gonzalez J, Connell PH, Eyles CJ. A terrestrial gamma-ray flash and ionospheric ultraviolet emissions powered by lightning. Science. 2020 Jan 10;367(6474):183-186. doi: 10.1126/science.aax3872. Epub 2019 Dec 11. PMID: 31826957.
Copy Download .nbib Format: NLM
Sunscreen Effect Exerted by Secondary Carotenoids and Mycosporine-like Amino Acids in the Aeroterrestrial Chlorophyte .

Plants (Basel, Switzerland)

Zaytseva A, Chekanov K, Zaytsev P, Bakhareva D, Gorelova O, Kochkin D, Lobakova E.
PMID: 34961072
Plants (Basel). 2021 Nov 26;10(12). doi: 10.3390/plants10122601.

The microalga

Cite
Zaytseva A, Chekanov K, Zaytsev P, et al. Sunscreen Effect Exerted by Secondary Carotenoids and Mycosporine-like Amino Acids in the Aeroterrestrial Chlorophyte . Plants (Basel). 2021;10(12)doi: 10.3390/plants10122601.
Zaytseva, A., Chekanov, K., Zaytsev, P., Bakhareva, D., Gorelova, O., Kochkin, D., & Lobakova, E. (2021). Sunscreen Effect Exerted by Secondary Carotenoids and Mycosporine-like Amino Acids in the Aeroterrestrial Chlorophyte . Plants (Basel, Switzerland), 10(12), . https://doi.org/10.3390/plants10122601
Zaytseva, Anna, et al. "Sunscreen Effect Exerted by Secondary Carotenoids and Mycosporine-like Amino Acids in the Aeroterrestrial Chlorophyte ." Plants (Basel, Switzerland) vol. 10,12 (2021). doi: https://doi.org/10.3390/plants10122601
Zaytseva A, Chekanov K, Zaytsev P, Bakhareva D, Gorelova O, Kochkin D, Lobakova E. Sunscreen Effect Exerted by Secondary Carotenoids and Mycosporine-like Amino Acids in the Aeroterrestrial Chlorophyte . Plants (Basel). 2021 Nov 26;10(12). doi: 10.3390/plants10122601. PMID: 34961072.
Copy Download .nbib Format: NLM
[Peculiarities of atherosclerotic lesions of lower limb arteries in patients with type 2 diabetes mellitus].

Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery

Koshkina IV, Nastavsheva OD, Sukhorukov EA, Koshkin VM.
PMID: 25267221
Angiol Sosud Khir. 2014;20(3):24-8.

The authors carried out a comparative study of the arterial vascular wall in patients presenting with atherosclerosis obliterans of lower-limb arteries on the background of diabetes mellitus and without it, thoroughly describing the methodology and reporting the results of...

Cite
Koshkina IV, Nastavsheva OD, Sukhorukov EA, et al. Osobennosti ateroskleroticheskogo porazheniia arteriĭ nizhnikh konechnosteĭ u bol'nykh sakharnym diabetom 2 tipa. [Peculiarities of atherosclerotic lesions of lower limb arteries in patients with type 2 diabetes mellitus]. Angiol Sosud Khir. 2014;20(3):24-8
Koshkina, I. V., Nastavsheva, O. D., Sukhorukov, E. A., & Koshkin, V. M. (2014). Osobennosti ateroskleroticheskogo porazheniia arteriĭ nizhnikh konechnosteĭ u bol'nykh sakharnym diabetom 2 tipa. [Peculiarities of atherosclerotic lesions of lower limb arteries in patients with type 2 diabetes mellitus]. Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery, 20(3), 24-8.
Koshkina, I V, et al. "Osobennosti ateroskleroticheskogo porazheniia arteriĭ nizhnikh konechnosteĭ u bol'nykh sakharnym diabetom 2 tipa." [Peculiarities of atherosclerotic lesions of lower limb arteries in patients with type 2 diabetes mellitus]. Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery vol. 20,3 (2014): 24-8.
Koshkina IV, Nastavsheva OD, Sukhorukov EA, Koshkin VM. Osobennosti ateroskleroticheskogo porazheniia arteriĭ nizhnikh konechnosteĭ u bol'nykh sakharnym diabetom 2 tipa. [Peculiarities of atherosclerotic lesions of lower limb arteries in patients with type 2 diabetes mellitus]. Angiol Sosud Khir. 2014;20(3):24-8. Russian. PMID: 25267221.
Copy Download .nbib Format: NLM
Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition.

Oncoimmunology

Shionoya Y, Kanaseki T, Miyamoto S, Tokita S, Hongo A, Kikuchi Y, Kochin V, Watanabe K, Horibe R, Saijo H, Tsukahara T, Hirohashi Y, Takahashi H, Sato N, Torigoe T.
PMID: 28344889
Oncoimmunology. 2017 Jan 03;6(2):e1274476. doi: 10.1080/2162402X.2016.1274476. eCollection 2017.

Cytotoxic T-lymphocytes (CTLs) lyse target cells after recognizing the complexes of peptides and MHC class I molecules (pMHC I) on cell surfaces. Tapasin is an essential component of the peptide-loading complex (PLC) and its absence influences the surface repertoire...

Cite
Shionoya Y, Kanaseki T, Miyamoto S, et al. Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition. Oncoimmunology. 2017;6(2):e1274476doi: 10.1080/2162402X.2016.1274476.
Shionoya, Y., Kanaseki, T., Miyamoto, S., Tokita, S., Hongo, A., Kikuchi, Y., Kochin, V., Watanabe, K., Horibe, R., Saijo, H., Tsukahara, T., Hirohashi, Y., Takahashi, H., Sato, N., & Torigoe, T. (2017). Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition. Oncoimmunology, 6(2), e1274476. https://doi.org/10.1080/2162402X.2016.1274476
Shionoya, Yosuke, et al. "Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition." Oncoimmunology vol. 6,2 (2017): e1274476. doi: https://doi.org/10.1080/2162402X.2016.1274476
Shionoya Y, Kanaseki T, Miyamoto S, Tokita S, Hongo A, Kikuchi Y, Kochin V, Watanabe K, Horibe R, Saijo H, Tsukahara T, Hirohashi Y, Takahashi H, Sato N, Torigoe T. Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition. Oncoimmunology. 2017 Jan 03;6(2):e1274476. doi: 10.1080/2162402X.2016.1274476. eCollection 2017. PMID: 28344889; PMCID: PMC5353923.
Copy Download .nbib Format: NLM
A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors.

European urology oncology

Khaki AR, Li A, Diamantopoulos LN, Miller NJ, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin V, Park J, Alva A, Bilen MA, Stewart T, Santos V, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P.
PMID: 33423945
Eur Urol Oncol. 2021 Jun;4(3):464-472. doi: 10.1016/j.euo.2020.12.006. Epub 2021 Jan 07.

BACKGROUND: While immune checkpoint inhibitors (ICIs) are approved in the first-line (1L) setting for cisplatin-unfit patients with programmed death-ligand 1 (PD-L1)-high tumors or for platinum (cisplatin/carboplatin)-unfit patients, response rates remain modest and outcomes vary with no clinically useful biomarkers...

Cite
Khaki AR, Li A, Diamantopoulos LN, et al. A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors. Eur Urol Oncol. 2021;4(3):464-472doi: 10.1016/j.euo.2020.12.006.
Khaki, A. R., Li, A., Diamantopoulos, L. N., Miller, N. J., Carril-Ajuria, L., Castellano, D., De Kouchkovsky, I., Koshkin, V., Park, J., Alva, A., Bilen, M. A., Stewart, T., Santos, V., Agarwal, N., Jain, J., Zakharia, Y., Morales-Barrera, R., Devitt, M., Nelson, A., Hoimes, C. J., Shreck, E., Gartrell, B. A., Sankin, A., Tripathi, A., Zakopoulou, R., Bamias, A., Rodriguez-Vida, A., Drakaki, A., Liu, S., Kumar, V., Lythgoe, M. P., Pinato, D. J., Murgic, J., Fröbe, A., Joshi, M., Isaacsson Velho, P., Hahn, N., Alonso Buznego, L., Duran, I., Moses, M., Barata, P., Galsky, M. D., Sonpavde, G., Yu, E. Y., Shankaran, V., Lyman, G. H., & Grivas, P. (2021). A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors. European urology oncology, 4(3), 464-472. https://doi.org/10.1016/j.euo.2020.12.006
Khaki, Ali Raza, et al. "A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors." European urology oncology vol. 4,3 (2021): 464-472. doi: https://doi.org/10.1016/j.euo.2020.12.006
Khaki AR, Li A, Diamantopoulos LN, Miller NJ, Carril-Ajuria L, Castellano D, De Kouchkovsky I, Koshkin V, Park J, Alva A, Bilen MA, Stewart T, Santos V, Agarwal N, Jain J, Zakharia Y, Morales-Barrera R, Devitt M, Nelson A, Hoimes CJ, Shreck E, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Rodriguez-Vida A, Drakaki A, Liu S, Kumar V, Lythgoe MP, Pinato DJ, Murgic J, Fröbe A, Joshi M, Isaacsson Velho P, Hahn N, Alonso Buznego L, Duran I, Moses M, Barata P, Galsky MD, Sonpavde G, Yu EY, Shankaran V, Lyman GH, Grivas P. A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors. Eur Urol Oncol. 2021 Jun;4(3):464-472. doi: 10.1016/j.euo.2020.12.006. Epub 2021 Jan 07. PMID: 33423945; PMCID: PMC8169524.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 56 entries